Preparing lung cancer patients for surgery with a home program
Official title: Digitally Enabled Prehabilitation in a Community-based Setting for Patients Undergoing Lung Cancer Surgery
Run by University of Melbourne · NCT06716437 · Data updated 2026-11-12
This study is testing a home program that helps lung cancer patients get stronger and healthier before their surgery through exercise and support from a physiotherapist.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 25 (estimated) |
| Sponsor | University of Melbourne Academic / other |
| Locations | 1 site (Parkville, Victoria) |
| Status | Recruiting |
| Started | January 24, 2025 |
| Main results expected | May 30, 2025 |
| Study ends | June 30, 2025 |
| Registry record updated | April 22, 2025 |
| Trial ID | NCT06716437 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older diagnosed with lung cancer and scheduled for lung resection surgery who can understand English and use a smartphone.
✕Probably not a fit
Patients with other cancer diagnoses, those scheduled for surgery in less than one week, or individuals with unstable psychiatric or cognitive disorders may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This research focuses on a prehabilitation program designed for patients with lung cancer who are scheduled for lung resection surgery. The program includes education, inspiratory muscle training, physical activity coaching, and home-based exercise training, all supported by a mobile app and weekly telehealth sessions with a physiotherapist. Participants will be assessed on their lung function, respiratory muscle strength, and functional capacity before and after the intervention to evaluate its effectiveness in improving their physical and respiratory function in preparation for surgery.
Why it matters
Potential benefit: If successful, this program could enhance recovery and reduce hospital stay for lung cancer patients undergoing surgery.
How similar studies have gone: Other studies have shown promising results with prehabilitation approaches in surgical patients, indicating potential success for this intervention.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of lung cancer and scheduled for lung resection surgery * Ability to understand and speak English to follow instructions and complete the intended assessments. * Age ≥ 18 years at the point of baseline screening * Provide written informed consent for the trial * Sufficient digital literacy to use a smartphone and mobile app * No contraindications for exercise Exclusion Criteria: * Other cancer diagnoses than lung cancer * Surgery scheduled in less than one week * Unstable psychiatric, cognitive or substance abuse disorders that would interfere with cooperation with the requirements of the trial
Where it's running
-
The University of Melbourne, Department of Physiotherapy
Parkville, Victoria, Australia Recruiting
Study contacts
- Principal investigator: Linda Denehy, PhD — University of Melbourne
- Study coordinator: Lara Edbrooke, PhD
- Email: larae@unimelb.edu.au
- Phone: +61 3 90354213
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Integrated genomic and clinical database for cancer biomarker discovery
Researchers are building a combined genomic and clinical database at Samsung Medical Center to test biomarkers for cancer diagnosis, treatment choice, and predicting how well treatments work.
-
Understanding what patients want from NSCLC treatment monitoring
Researchers are testing how patients with non-small cell lung cancer feel about and prefer monitoring their symptoms during treatment, with input from patients, caregivers, and clinicians.
-
PD-L1-targeted PET probe to map PD-L1 in solid tumors
A PET tracer called 18F-F-PDL1-3 is being tested to see if it can detect PD-L1 expression in primary and metastatic tumors to help guide personalized treatment.
-
Cardiorespiratory fitness after lobectomy versus sublobar resection in NSCLC
This study tests how different lung surgeries (lobectomy vs. sublobar resection) affect fitness levels after surgery in people with non-small cell lung cancer.
-
CAIX-targeted PET/CT imaging in solid tumors
Researchers are testing a CAIX-targeted PET/CT imaging agent to see if it detects and reflects CAIX levels in solid tumors like clear cell renal cell carcinoma, NSCLC, and breast cancer.
-
NUT Project: Nutritional Support in Thoracic Cancer
We’ll see if providing tailored nutrition guidance and assessment helps people with advanced lung cancer during their treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.